GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | October 09, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
7W9K | Q07699 | Cryo-EM structure of human Nav1.7-beta1-beta2 complex at 2.2 angstrom resolution | |
7W9L | Q07699 | Cryo-EM structure of human Nav1.7(E406K)-beta1-beta2 complex | |
7W9M | Q07699 | Cryo-EM structure of human Nav1.7(E406K) in complex with auxiliary beta subunits, ProTx-II and tetrodotoxin (S6IV pi helix conformer) | |
7W9P | Q07699 | Cryo-EM structure of human Nav1.7(E406K) in complex with auxiliary beta subunits, huwentoxin-IV and saxitoxin (S6IV pi helix conformer) | |
7W9T | Q07699 | Cryo-EM structure of human Nav1.7(E406K) in complex with auxiliary beta subunits, huwentoxin-IV and saxitoxin (S6IV alpha helix conformer) | |
6J8J | Q07699 | Structure of human voltage-gated sodium channel Nav1.7 in complex with auxiliary beta subunits, ProTx-II and tetrodotoxin (Y1755 down) | Sodium channel subunit beta-2, Sodium channel protein type 9 subunit alpha, Sodium channel subunit beta-1 |
6J8G | Q07699 | Structure of human voltage-gated sodium channel Nav1.7 in complex with auxiliary beta subunits, huwentoxin-IV and saxitoxin (Y1755 up) | Sodium channel subunit beta-2, Sodium channel protein type 9 subunit alpha, Sodium channel subunit beta-1 |
7XVE | Q07699 | Human Nav1.7 mutant class-I | |
7XVF | Q07699 | Nav1.7 mutant class2 | |
8I5B | Q07699 | Structure of human Nav1.7 in complex with bupivacaine | |
8I5G | Q07699 | Structure of human Nav1.7 in complex with PF-05089771 | |
8I5X | Q07699 | Structure of human Nav1.7 in complex with Vinpocetine | |
8I5Y | Q07699 | Structure of human Nav1.7 in complex with vixotrigine | |
8J4F | Q07699 | Structure of human Nav1.7 in complex with Hardwickii acid | |
6AGF | Q07699 | Structure of the human voltage-gated sodium channel Nav1.4 in complex with beta1 | Sodium channel protein PaFPC1, Mu-diguetoxin-Dc1a |
7XM9 | Q07699 | Cryo-EM structure of human NaV1.7/beta1/beta2-XEN907 | |
7XM9 | Q07699 | Cryo-EM structure of human NaV1.7/beta1/beta2-XEN907 | |
7XMF | Q07699 | Cryo-EM structure of human NaV1.7/beta1/beta2-Nav1.7-IN2 | |
7XMF | Q07699 | Cryo-EM structure of human NaV1.7/beta1/beta2-Nav1.7-IN2 | |
7XMG | Q07699 | Cryo-EM structure of human NaV1.7/beta1/beta2-TCN-1752 | |
7XMG | Q07699 | Cryo-EM structure of human NaV1.7/beta1/beta2-TCN-1752 | |
8G1A | Q07699 | Cryo-EM structure of Nav1.7 with CBD | |
8S9B | Q07699 | Cryo-EM structure of Nav1.7 with LCM | |
8S9C | Q07699 | Cryo-EM structure of Nav1.7 with CBZ | |
7W77 | Q07699 | cryo-EM structure of human NaV1.3/beta1/beta2-bulleyaconitineA | |
7W7F | Q07699 | Cryo-EM structure of human NaV1.3/beta1/beta2-ICA121431 | |
8FHD | Q07699 | Cryo-EM structure of human voltage-gated sodium channel Nav1.6 | |
8XMM | Q07699 | Voltage-gated sodium channel Nav1.7 variant M9 | |
8XMN | Q07699 | Voltage-gated sodium channel Nav1.7 variant M2 | |
8XMO | Q07699 | Voltage-gated sodium channel Nav1.7 variant M4 | |
8THG | Q07699 | Cryo-EM structure of Nav1.7 with RLZ | |
8THH | Q07699 | Cryo-EM structure of Nav1.7 with LTG | |
6QYN | Q07820 | Structure of MBP-Mcl-1 in complex with compound 10d | |
8SVY | Q07820 | MBP-Mcl1 in complex with ligand 10 | |
6QYO | Q07820 | Structure of MBP-Mcl-1 in complex with compound 18a | |
6QGD | Q07820 | Structure of human Mcl-1 in complex with thienopyrimidine inhibitor | |
6QZ7 | Q07820 | Structure of MBP-Mcl-1 in complex with compound 8b | |
6YBK | Q07820 | Structure of MBP-Mcl-1 in complex with compound 4d | |
6QXJ | Q07820 | Structure of MBP-Mcl-1 in complex with compound 6a | |
6QYL | Q07820 | Structure of MBP-Mcl-1 in complex with compound 8a | |
6QYK | Q07820 | Structure of MBP-Mcl-1 in complex with compound 7a | |
6YBL | Q07820 | Structure of MBP-Mcl-1 in complex with compound 9m | |
8G3S | Q07820 | MBP-Mcl1 in complex with ligand 11 | |
8G3T | Q07820 | MBP-Mcl1 in complex with ligand 12 | |
8G3U | Q07820 | MBP-Mcl1 in complex with ligand 21 | |
8G3W | Q07820 | MBP-Mcl1 in complex with ligand 28 | |
8G3X | Q07820 | MBP-Mcl1 in complex with ligand 32 | |
8G3Y | Q07820 | MBP-Mcl1 in complex with ligand 34 | |
8T6F | Q07820 | Crystal structure of human MBP-Myeloid cell leukemia 1 (Mcl-1) in complex with BRD810 inhibitor | |
4WGI | Q07820 | A Single Diastereomer of a Macrolactam Core Binds Specifically to Myeloid Cell Leukemia 1 (MCL1) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024